Trends in Hallucinogen-associated Emergency Department Visits and Hospitalizations in California from 2016–2021
Steven Tate, Nicolas Garel, Kristin Nash, Anna Lembke
medRxiv August 20, 2023 preprint DOI: 10.1101/2023.08.18.23294275 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Descriptive study |
|---|---|
| Population | Emergency department visits and hospitalizations recorded in California Department of Healthcare Access and Information (HCAI) data, 2016-2021 |
| Duration | 2016 to 2021 |
| Citations | 1 |
| Key points | Hallucinogen-associated emergency department visit rates increased 69% between 2016 and 2021, versus a 24% decrease for alcohol and a 1.9% decrease for cannabis, and hallucinogen-associated hospitalization rates rose 74%, versus 11% for alcohol and 19% for cannabis. The authors characterize the increase as large in relative but small in absolute terms and argue that ICD-10 coding limits understanding of harms. |
Abstract
Abstract Objectives Hallucinogens encompass a diverse range of compounds with increasing scientific and public interest. Risks associated with hallucinogen use are poorly understood. This study aims to evaluate the trends in hallucinogen-related emergency department visits and hospitalizations in California from 2016 to 2021, as compared to alcohol and cannabis visits and hospitalizations Methods We conducted a descriptive study on publicly available data on diagnosis codes associated with emergency department (ED) visits and hospitalizations from the California Department of Healthcare Access and Information (HCAI) to describe hallucinogen, alcohol, and cannabis associated encounters.
Results: Rates of hallucinogen associated ED visits increased by 69% between 2016 and 2021 compared to a 24% decrease and 1.9% decrease in rates of alcohol associated and cannabis associated ED visits respectively. Rates of hallucinogen associated hospitalizations increased by 74% compared to a 11% increase in alcohol associated hospitalizations and a 19% increase in cannabis associated hospitalizations.
Conclusions: The large relative, but small absolute, increase in hallucinogen associated ED visits and hospitalizations is concerning given changing public perception and increasing use of these substances. The categorization of a large number of compounds as hallucinogens limits our ability to understand trends in harms with ICD-10 codes. Improved systems for surveillance of potential harms of hallucinogen use are needed.
Citations in the library
Cites 4
- Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine Journal of Neuroscience November 30, 2020
- Preparing for the Bursting of the Psychedelic Hype Bubble. JAMA Psychiatry October 1, 2022
- Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP Addiction August 17, 2022
- Hallucinogen use among young adults ages 19–30 in the United States: Changes from 2018 to 2021 Addiction June 7, 2023